Kazia Therapeutics (KZIA) Research & Development (2009 - 2024)
Kazia Therapeutics' (KZIA) quarterly Research & Development came in at -$3.7 million in Q4 2016, up 4.8% on a QoQ basis from -$3.8 million in Q4 2009.
Powered by 
Analysis
Kazia Therapeutics (KZIA) Research & Development (2009 - 2024) Analysis & Trends
Kazia Therapeutics (KZIA) has 2 years of Research & Development data on file, last reported at -$3.7 million in Q4 2016.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -486.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 651.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 394.92 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 612.28 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 413.13 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 97.90 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 210.03 Mn |
| 10 | Kazia Therapeutics | 91.11 Mn | 91.11 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -2.80 Mn |
| Jun 30, 2024 | -11.45 Mn |
| Dec 31, 2023 | -10.13 Mn |
| Dec 31, 2022 | -6.15 Mn |
| Dec 31, 2021 | 8.00 Mn |
| Aug 30, 2013 | -2.11 Mn |
| Dec 31, 2012 | -4.73 Mn |
| Dec 31, 2011 | -110,000.00 |
| Dec 31, 2010 | -604,000.00 |
| Jun 30, 2010 | -533,957.92 |
| Dec 31, 2009 | -1.40 Mn |